MAPT and Alzheimer disease: Tau in AD patients can directly bind oligomeric Aβ protein, reduce the level of phosphorylated tau protein, and reduce excitotoxicity, anti-oxidation, anti-apoptosis and other mechanisms to jointly build neuroprotective function (Jahanshahi et al., 2021).